Adverum Biotechnologies, Inc. Restructuring Charges
Adverum Biotechnologies, Inc. reported Restructuring Charges of $4.68 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2024-03-18
- Adverum Biotechnologies, Inc. restructuring charges for the quarter ending 2022-12-31 was $0.00.
- Adverum Biotechnologies, Inc. restructuring charges for the quarter ending 2015-12-31 was $2.60M.
- Adverum Biotechnologies, Inc. restructuring charges for fiscal 2022 was $4.68M.
- Adverum Biotechnologies, Inc. restructuring charges for fiscal 2015 was $2.57M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $4.68M 10-K · filed 2024-03-18 | |
| 2022-09-30 | $4.68M 10-Q · filed 2022-11-10 | ||
| 2015-12-31 | $2.60M 10-K · filed 2017-03-09 | $2.57M 10-K · filed 2018-03-06 |